157 related articles for article (PubMed ID: 11866987)
1. [Detection of the expression of Smad4, transforming growth factor beta(1) and beta receptor II proteins in paraffin-embedded human pancreatic cancer tissues].
Gu L; Chen J; Liu T; Li L; Lu Z; Luo Y
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):439-42. PubMed ID: 11866987
[TBL] [Abstract][Full Text] [Related]
2. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
[TBL] [Abstract][Full Text] [Related]
3. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
4. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B
Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501
[TBL] [Abstract][Full Text] [Related]
5. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
[TBL] [Abstract][Full Text] [Related]
6. Effects of human papillomavirus type 16 E7 protein on the growth of cervical carcinoma cells and immuno-escape through the TGF-beta1 signaling pathway.
Xu Q; Wang S; Xi L; Wu S; Chen G; Zhao Y; Wu Y; Ma D
Gynecol Oncol; 2006 Apr; 101(1):132-9. PubMed ID: 16269171
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
[TBL] [Abstract][Full Text] [Related]
10. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
[TBL] [Abstract][Full Text] [Related]
11. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
[TBL] [Abstract][Full Text] [Related]
12. [Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance].
Zhang BY; Zhang JY; Zhao K; Wu LQ
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):846-9. PubMed ID: 16083599
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.
Villanueva A; García C; Paules AB; Vicente M; Megías M; Reyes G; de Villalonga P; Agell N; Lluís F; Bachs O; Capellá G
Oncogene; 1998 Oct; 17(15):1969-78. PubMed ID: 9788440
[TBL] [Abstract][Full Text] [Related]
15. Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.
Wagner M; Kleeff J; Lopez ME; Bockman I; Massaqué J; Korc M
Int J Cancer; 1998 Oct; 78(2):255-60. PubMed ID: 9754660
[TBL] [Abstract][Full Text] [Related]
16. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
[TBL] [Abstract][Full Text] [Related]
17. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
[TBL] [Abstract][Full Text] [Related]
18. Correlation between S100A11 and the TGF-β
Ji YF; Li T; Jiang F; Ni WK; Guan CQ; Liu ZX; Lu CH; Ni RZ; Wu W; Xiao MB
Mol Cell Biochem; 2019 Jan; 450(1-2):53-64. PubMed ID: 29922945
[TBL] [Abstract][Full Text] [Related]
19. Role of transforming growth factor-beta signaling pathway in pathogenesis of benign biliary stricture.
Geng ZM; Zheng JB; Zhang XX; Tao J; Wang L
World J Gastroenterol; 2008 Aug; 14(31):4949-54. PubMed ID: 18756605
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]